Tumor genomics, also known as cancer genomics, is an emerging sub-discipline in genomics, mainly through the high-throughput sequencing technology to associate genes with cancer. Tumor is a disease caused by the accumulation of DNA mutations that leads to an uncontrolled proliferation of cells and the formation of new organisms. The main goal of tumor genomics is to provide new methods for tumor diagnosis, tumor clinical outcome prediction and tumor target treatment by identifying new oncogenes or tumor suppressor genes. Market Analysis and Insights: Global Tumor Genomics Market The global Tumor Genomics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Genomics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Genomics market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Genomics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Genomics market. Global Tumor Genomics Scope and Market Size Tumor Genomics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Genomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Assays and Kits Instrument Segment by Application Diagnostics and Monitoring Drug Discovery and Development Biomarker Discovery By Region North America United States Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Abbott Laboratories Agilent Technologies, Inc Bio-Rad Laboratories, Inc. Danaher Corporation F. Hoffmann-La Roche Ltd Fluidigm Corporation General Electric Company Illumina, Inc. Merck KGaA Myriad Genetics, Inc. Pacific Biosciences of California, Inc. PerkinElmer QIAGEN Siemens Healthineers AG Thermo Fisher Scientific Inc.
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Tumor Genomics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Assays and Kits 1.2.3 Instrument 1.3 Market by Application 1.3.1 Global Tumor Genomics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Diagnostics and Monitoring 1.3.3 Drug Discovery